Oral loading with propafenone: A placebo-controlled study in elderly and nonelderly patients with recent onset atrial fibrillation

被引:18
|
作者
Boriani, G
Biffi, M
Capucci, A
Botto, GL
Broffoni, T
Rubino, I
Della Casa, S
Sanguinetti, M
Branzi, A
Magnani, B
机构
[1] Univ Bologna, Inst Cardiol, I-40138 Bologna, Italy
[2] Osped Civile, Dept Cardiol, Lugo, Spain
[3] Osped S Anna, Dept Cardiol, Como, Italy
来源
关键词
antiarrhythmic drugs; atrial fibrillation; conversion; Holter monitoring;
D O I
10.1111/j.1540-8159.1998.tb01202.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The efficacy and safety of propafenone as an oral loading dose (600-mg single oral dose) in converting recent-onset atrial fibrillation (less than or equal to 7 days duration) to sinus rhythm were evaluated in a single-blind, placebo-controlled study according to patients' age. Overall, 240 hospitalized patients, NYHA Class less than or equal to 2 without signs or symptoms of heart failure were enrolled: among patients aged less than or equal to 60 years, 55 were allocated to propafenone treatment and 59 to placebo, respectively, and among patients aged > 60 years, 64 were allocated to propafenone treatment and 62 to placebo, respectively. Results: In each age group, the likelihood of conversion to sinus rhythm was significantly greater after propafenone compared with placebo at 3 and 8 hours. For patients aged less than or equal to 60 years, corresponding odd ratios were 3.78 (95% CI = 1.80-7.92, P = 0.04) at 3 hours and 4.74 (95% CI = 2.22-10.54, P = 0.02) at 8 hours; for patients aged > 60 years odd ratios were 5.03 (95% CI = 2.08-12.12, P = 0.02) at 3 hours and 6.75 (95% CI = 3.28-73.86, P = 0.01) at 8 hours, respectively. Logistic regression analysis showed that conversion to sinus rhythm within 3 hours was predicted by age less than or equal to 60 years IP = 0.0064) and by propafenone treatment IP ( 0.0001), and conversion to sinus rhythm within 8 hours was predicted by age less than or equal to 60 years(P = 0.0467) and by propafenone treatment (P ( 0.0001). The occurrence of adverse effects was observed in 14%-16% of propafenone treated patients and in 8% of placebo treated patients without significant differences according to age. In conclusion, in patients with recent-onset atrial fibrillation without signs of heart failure, propafenone as a single oral loading dose is effective. It is also effective in selected elderly subjects with a favorable safety profile. Moreover, spontaneous conversion to sin us rhythm appears to occur less frequently in elderly patients.
引用
收藏
页码:2465 / 2469
页数:5
相关论文
共 50 条
  • [1] Recent-onset atrial fibrillation: Placebo-controlled evaluation of the efficacy of propafenone in elderly subjects
    Boriani, G
    Capucci, A
    Biffi, M
    Botto, G
    Rubino, I
    DellaCasa, S
    Broffoni, T
    Sanguinetti, M
    Magnani, B
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 51140 - 51140
  • [2] Propafenone as a single oral loading dose vs placebo in recent onset atrial fibrillation: Is it safe?
    Capucci, A
    Boriani, G
    Biffi, M
    Rubino, I
    Villani, GQ
    Aschieri, D
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 51139 - 51139
  • [3] EFFECTIVENESS OF INTRAVENOUS PROPAFENONE FOR CONVERSION OF RECENT-ONSET ATRIAL-FIBRILLATION - A PLACEBO-CONTROLLED STUDY
    BELLANDI, F
    CANTINI, F
    PEDONE, T
    PALCHETTI, R
    BAMOSHMOOSH, M
    DABIZZI, RP
    CLINICAL CARDIOLOGY, 1995, 18 (11) : 631 - 634
  • [4] Intravenous propafenone versus intravenous amiodarone in the management of atrial fibrillation of recent onset: A placebo-controlled study
    Kochiadakis, GE
    Igoumenidis, NE
    Simantirakis, EN
    Marketou, ME
    Parthenakis, FI
    Mezilis, NE
    Vardas, PE
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1998, 21 (11): : 2475 - 2479
  • [5] Intravenous propafenone versus digoxin in recent onset atrial fibrillation. A placebo-controlled, randomized study
    Bianconi, L
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 370A - 370A
  • [6] Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm: A prospective parallel placebo-controlled multicentre study
    Capucci, A
    Villani, GQ
    Aschieri, D
    Piepoli, M
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1999, 68 (02) : 187 - 196
  • [7] Efficacy of propafenone for maintaining sinus rhythm in patients with recent onset or persistent atrial fibrillation after conversion: a randomized, placebo-controlled study
    Dogan, A
    Nazli, C
    Ergene, O
    Kinay, O
    Altinbas, A
    Ucarci, Y
    Ergene, U
    Gedikli, O
    EUROPEAN HEART JOURNAL, 2003, 24 : 513 - 513
  • [8] Efficacy of propafenone for maintaining sinus rhythm in patients with recent onset or persistent atrial fibrillation after conversion: a randomized, placebo-controlled study
    Dogan, A
    Ergene, O
    Nazli, C
    Kinay, O
    Altinbas, A
    Ucarci, Y
    Ergene, U
    Ozaydin, M
    Gedikli, O
    ACTA CARDIOLOGICA, 2004, 59 (03) : 255 - 261
  • [9] PROPAFENONE ORAL LOADING DOSE PLUS DIGITALIS IN CONVERTING ATRIAL-FIBRILLATION TO SINUS RHYTHM - A PLACEBO-CONTROLLED MULTICENTER STUDY
    CAPUCCI, A
    VILLANI, GQ
    CIRCULATION, 1995, 92 (08) : 3731 - 3731
  • [10] Oral propafenone cost-effectiveness in patients with recent onset atrial fibrillation
    Villani, GQ
    Piepoli, MF
    Marrazzo, N
    Rosi, A
    Capucci, A
    EUROPEAN HEART JOURNAL, 2001, 22 : 327 - 327